SCHEMBL8875205

SCHEMBL8875205

Cc1c(-c2ccccc2)oc2c(CNC(=O)CCl)cccc2c1=O

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.49
LMNA P02545 6/20 0.49
MAPT P10636 5/20 0.48
SMN1; SMN2 Q16637 4/20 0.48
NPSR1 Q6W5P4 3/20 0.48
GAA P10253 1/20 0.48
GLA P06280 2/20 0.46
MEN1 O00255 1/20 0.46
KMT2A Q03164 1/20 0.46
HTR1A P08908 2/20 0.45
ADRA1A P35348 2/20 0.45
CYP3A4 P08684 2/20 0.45
KDM4E B2RXH2 1/20 0.45
CYP1A2 P05177 1/20 0.45
CHRM2 P08172 1/20 0.45
ADRA2A P08913 1/20 0.45
ADORA3 P0DMS8 1/20 0.45
CYP2D6 P10635 1/20 0.45
CHRM1 P11229 1/20 0.45
ACHE P22303 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8875656 0.88 LMNA (0.46) ALDH1A1LMNAMAPTSMN1; SMN2NPSR1
SCHEMBL8876518 0.83 MAPT (0.49) ALDH1A1LMNAMAPTSMN1; SMN2NPSR1
SCHEMBL8875855 0.82 LMNA (0.48) ALDH1A1LMNAMAPTSMN1; SMN2NPSR1
SCHEMBL5116298 0.82 LMNA (0.50) ALDH1A1LMNAMAPTSMN1; SMN2NPSR1
SCHEMBL8875991 0.82 LMNA (0.47) ALDH1A1LMNAMAPTSMN1; SMN2NPSR1
SCHEMBL5118184 0.81 LMNA (0.54) ALDH1A1LMNAMAPTSMN1; SMN2NPSR1
SCHEMBL8875368 0.80 GLA (0.63) ALDH1A1LMNAMAPTSMN1; SMN2NPSR1
SCHEMBL14266220 0.79 LMNA (0.55) ALDH1A1LMNAMAPTSMN1; SMN2NPSR1
SCHEMBL8874213 0.79 LMNA (0.49) ALDH1A1LMNAMAPTSMN1; SMN2NPSR1
SCHEMBL7052213 0.78 HTR1A (0.58) ALDH1A1LMNAMAPTSMN1; SMN2NPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5605896-A Bicyclic heterocyclic derivatives having α1 adrenergic and 5HT1A activities RECORDATI S.A., CHEMICAL AND PHARMACEUTICAL COMPANY (CH) 1997-02-25 US disclosed
US-5474994-A Treating hypertension, urethral and lower urinary tract contractions RECORDATI S.A., CHEMICAL AND PHARMACEUTICAL COMPANY (CH) 1995-12-12 US disclosed
US-5453518-A Antispasmodic agents, treatment of urinary incontinence RECORDATI S.A., CHEMICAL AND PHARMACEUTICAL COMPANY (CH) 1995-09-26 US disclosed
EP-0566288-B1 Flavone derivatives RECORDATI CHEM PHARM (CH) 1995-08-02 EP disclosed
US-5403842-A Adrenergic blocking and antiserotonine agents; urogenital disorders including spasms of the urethral tract and prostrate problems RECORDATI S.A., CHEMICAL AND PHARMACEUTICAL COMPANY (CH) 1995-04-04 US disclosed
WO-1993017007-A1 HETEROBICYCLIC COMPOUNDS RECORDATI INDUSTRIA CHIMICA E FARMACEUTICA S.P.A. (IT) 1993-09-02 WO disclosed
EP-0558245-A1 Heterobicyclic compounds as antagogists of alpha-1 adrenergic and SHT1A receptors RECORDATI S.A. CHEMICAL and PHARMACEUTICAL COMPANY (CH) 1993-09-01 EP disclosed